Long noncoding RNA FEZF1-AS1 promotes the motility of esophageal squamous cell carcinoma through Wnt/β-catenin pathway

References

• Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108. doi:10.3322/caac.2126225651787
   PubMed Web of Science ®Google Scholar
• Smyth EC, Lagergren J, Fitzgerald RC, et al. Oesophageal cancer. Nat Rev Dis Primers. 2017;3:17048. doi:10.1038/nrdp.2017.4828748917
   PubMed Web of Science ®Google Scholar
• Yang L, Sun K, Chu J, et al. Long non-coding RNA FTH1P3 regulated metastasis and invasion of esophageal squamous cell carcinoma through SP1/NF-kB pathway. Biomed Pharmacother. 2018;106:1570–1577. doi:10.1016/j.biopha.2018.07.12930119232
   PubMed Web of Science ®Google Scholar
• Arnold M, Soerjomataram I, Ferlay J, Forman D. Global incidence of oesophageal cancer by histological subtype in 2012. Gut. 2015;64(3):381–387. doi:10.1136/gutjnl-2014-30812425320104
   PubMed Web of Science ®Google Scholar
• Li DJ, Shi M, Wang Z. RUNX3 reverses cisplatin resistance in esophageal squamous cell carcinoma via suppression of the protein kinase B pathway. Thorac Cancer. 2016;7(5):570–580. doi:10.1111/1759-7714.1237027766776
   PubMed Web of Science ®Google Scholar
• Yazbeck R, Jaenisch SE, Watson DI. From blood to breath: new horizons for esophageal cancer biomarkers. World J Gastroenterol. 2016;22(46):10077–10083. doi:10.3748/wjg.v22.i46.1007728028355
   PubMed Web of Science ®Google Scholar
• Sun K, Zhao X, Wan J, et al. The diagnostic value of long non-coding RNA MIR31HG and its role in esophageal squamous cell carcinoma. Life Sci. 2018;202:124–130. doi:10.1016/j.lfs.2018.03.05029605445
   PubMed Web of Science ®Google Scholar
• Cheetham SW, Gruhl F, Mattick JS, Dinger ME. Long noncoding RNAs and the genetics of cancer. Br J Cancer. 2013;108(12):2419–2425. doi:10.1038/bjc.2013.23323660942
   PubMed Web of Science ®Google Scholar
• Schmitt AM, Chang HY. Long noncoding RNAs in cancer pathways. Cancer Cell. 2016;29(4):452–463. doi:10.1016/j.ccell.2016.03.01027070700
   PubMed Web of Science ®Google Scholar
• Lin C, Yang L. Long noncoding RNA in cancer: wiring signaling circuitry. Trends Cell Biol. 2018;28(4):287–301. doi:10.1016/j.tcb.2017.11.00829274663
   PubMed Web of Science ®Google Scholar
• Ferre F, Colantoni A, Helmer-Citterich M. Revealing protein-lncRNA interaction. Brief Bioinform. 2016;17(1):106–116. doi:10.1093/bib/bbv03126041786
   PubMed Web of Science ®Google Scholar
• Ballantyne MD, McDonald RA, Baker AH. lncRNA/MicroRNA interactions in the vasculature. Clin Pharmacol Ther. 2016;99(5):494–501. doi:10.1002/cpt.35526910520
   PubMed Web of Science ®Google Scholar
• Gibb EA, Brown CJ, Lam WL. The functional role of long non-coding RNA in human carcinomas. Mol Cancer. 2011;10:38. doi:10.1186/1476-4598-10-9321489289
   PubMed Web of Science ®Google Scholar
• Hosseini ES, Meryet-Figuiere M, Sabzalipoor H, Kashani HH, Nikzad H, Asemi Z. Dysregulated expression of long noncoding RNAs in gynecologic cancers. Mol Cancer. 2017;16(1):107. doi:10.1186/s12943-017-0671-228637507
   PubMedGoogle Scholar
• He W, Zhong G, Jiang N, et al. Long noncoding RNA BLACAT2 promotes bladder cancer-associated lymphangiogenesis and lymphatic metastasis. J Clin Invest. 2018;128(2):861–875. doi:10.1172/JCI9621829355840
   PubMed Web of Science ®Google Scholar
• Zhang XD, Huang GW, Xie YH, et al. The interaction of lncRNA EZR-AS1 with SMYD3 maintains overexpression of EZR in ESCC cells. Nucleic Acids Res. 2018;46(4):1793–1809. doi:10.1093/nar/gkx125929253179
   PubMed Web of Science ®Google Scholar
• Chen N, Guo D, Xu Q, et al. Long non-coding RNA FEZF1-AS1 facilitates cell proliferation and migration in colorectal carcinoma. Oncotarget. 2016;7(10):11271–11283. 26848625
   PubMedGoogle Scholar
• Liu YW, Xia R, Lu K, et al. LincRNAFEZF1-AS1 represses p21 expression to promote gastric cancer proliferation through LSD1-Mediated H3K4me2 demethylation. Mol Cancer. 2017;16(1):39. doi:10.1186/s12943-017-0588-928209170
   PubMedGoogle Scholar
• He R, Zhang FH, Shen N. LncRNA FEZF1-AS1 enhances epithelial-mesenchymal transition (EMT) through suppressing E-cadherin and regulating WNT pathway in non-small cell lung cancer (NSCLC). Biomed Pharmacother. 2017;95:331–338. doi:10.1016/j.biopha.2017.08.05728858731
   PubMed Web of Science ®Google Scholar
• Wang YD, Sun XJ, Yin JJ, et al. Long non-coding RNA FEZF1-AS1 promotes cell invasion and epithelial-mesenchymal transition through JAK2/STAT3 signaling pathway in human hepatocellular carcinoma. Biomed Pharmacother. 2018;106:134–141. doi:10.1016/j.biopha.2018.05.11629957463
   PubMed Web of Science ®Google Scholar
• Wan J, Liu H, Feng Q, Liu J, Ming L. HOXB9 promotes endometrial cancer progression by targeting E2F3. Cell Death Dis. 2018;9(5):509. doi:10.1038/s41419-018-0556-329724991
   PubMedGoogle Scholar
• Wan J, Liu H, Yang L, Ma L, Liu J, Ming L. JMJD6 promotes hepatocellular carcinoma carcinogenesis by targeting CDK4. Int J Cancer. 2019;144(19):2489–2500. 30125344
   PubMedGoogle Scholar
• Wang K, Liu CY, Zhou LY, et al. APF lncRNA regulates autophagy and myocardial infarction by targeting miR-188-3p. Nat Commun. 2015;6:6779. doi:10.1038/ncomms777925858075
   PubMed Web of Science ®Google Scholar
• Wu X, Yan T, Wang Z, Wu X, Cao G, Zhang C. LncRNA ZEB2-AS1 promotes bladder cancer cell proliferation and inhibits apoptosis by regulating miR-27b. Biomed Pharmacother. 2017;96:299–304. doi:10.1016/j.biopha.2017.08.06028992472
   PubMed Web of Science ®Google Scholar
• Damas ND, Marcatti M, Come C, et al. SNHG5 promotes colorectal cancer cell survival by counteracting STAU1-mediated mRNA destabilization. Nat Commun. 2016;7:13875. doi:10.1038/ncomms1387528004750
   PubMed Web of Science ®Google Scholar
• Wilusz JE, Sunwoo H, Spector DL. Long noncoding RNAs: functional surprises from the RNA world. Genes Dev. 2009;23(13):1494–1504. doi:10.1101/gad.180090919571179
   PubMed Web of Science ®Google Scholar
• Mercer TR, Mattick JS. Structure and function of long noncoding RNAs in epigenetic regulation. Nat Struct Mol Biol. 2013;20(3):300–307. doi:10.1038/nsmb.248023463315
   PubMed Web of Science ®Google Scholar
• Chen C, He W, Huang J, et al. LNMAT1 promotes lymphatic metastasis of bladder cancer via CCL2 dependent macrophage recruitment. Nat Commun. 2018;9(1):3826. doi:10.1038/s41467-018-06152-x30237493
   PubMed Web of Science ®Google Scholar
• Xiao ZD, Han L, Lee H, et al. Energy stress-induced lncRNA FILNC1 represses c-Myc-mediated energy metabolism and inhibits renal tumor development. Nat Commun. 2017;8(1):783. doi:10.1038/s41467-017-00902-z28978906
   PubMedGoogle Scholar
• Ye H, Zhou Q, Zheng S, et al. FEZF1-AS1/miR-107/ZNF312B axis facilitates progression and Warburg effect in pancreatic ductal adenocarcinoma. Cell Death Dis. 2018;9(2):34. doi:10.1038/s41419-017-0052-129348628
   PubMedGoogle Scholar
• Zhang Z, Sun L, Zhang Y, Lu G, Li Y, Wei Z. Long non-coding RNA FEZF1-AS1 promotes breast cancer stemness and tumorigenesis via targeting miR-30a/Nanog axis. J Cell Physiol. 2018;233(11):8630–8638. doi:10.1002/jcp.2661129797562
   PubMed Web of Science ®Google Scholar
• Kun-Peng Z, Chun-Lin Z, Xiao-Long M. Antisense lncRNA FOXF1-AS1 promotes migration and invasion of osteosarcoma cells through the FOXF1/MMP-2/-9 pathway. Int J Biol Sci. 2017;13(9):1180–1191. doi:10.7150/ijbs.2172229104509
   PubMed Web of Science ®Google Scholar
• Goossens S, Vandamme N, Van Vlierberghe P, Berx G. EMT transcription factors in cancer development re-evaluated: beyond EMT and MET. Biochim Biophys Acta Rev Cancer. 2017;1868(2):584–591. doi:10.1016/j.bbcan.2017.06.00628669750
   PubMed Web of Science ®Google Scholar
• Wan J, Liu H, Ming L. Lysine crotonylation is involved in hepatocellular carcinoma progression. Biomed Pharmacother. 2019;111:976–982. doi:10.1016/j.biopha.2018.12.14830841477
   PubMed Web of Science ®Google Scholar
• Garg M. Epithelial-mesenchymal transition – activating transcription factors – multifunctional regulators in cancer. World J Stem Cells. 2013;5(4):188–195. doi:10.4252/wjsc.v5.i4.18824179606
   PubMedGoogle Scholar
• Katoh M. Multilayered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/betacatenin signaling activation (Review). Int J Mol Med. 2018;42(2):713–725. doi:10.3892/ijmm.2018.368929786110
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhou J, Xu YJ, Hu HB. Long non-coding RNA LINC00968 acts as oncogene in NSCLC by activating the Wnt signaling pathway. J Cell Physiol. 2018;233(4):3397–3406. doi:10.1002/jcp.2618628926089
   PubMed Web of Science ®Google Scholar
• Wang XL, Shi M, Xiang T, Bu YZ. Long noncoding RNA DGCR5 represses hepatocellular carcinoma progression by inactivating Wnt signaling pathway. J Cell Biochem. 2019;120(1):275–282. 30230592
   PubMed Web of Science ®Google Scholar